Boron-containing small molecules
First Claim
Patent Images
1. A pharmaceutical composition, comprising:
- (a) 1,3-dihydro-5-chloro-1-hydroxy-2,1-benzoxaborole, or a pharmaceutically acceptable salt thereof;
(b) a pharmaceutically acceptable excipient for use in an animal suffering from an infection by a microorganism.
2 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.
-
Citations
46 Claims
-
1. A pharmaceutical composition, comprising:
-
(a) 1,3-dihydro-5-chloro-1-hydroxy-2,1-benzoxaborole, or a pharmaceutically acceptable salt thereof; (b) a pharmaceutically acceptable excipient for use in an animal suffering from an infection by a microorganism. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)
-
- 35. A method of treating an infection in an animal, said method comprising administering to the animal a therapeutically effective amount of 1,3-dihydro-5-chloro-1-hydroxy-2,1-benzoxaborole, or a pharmaceutically acceptable salt thereof, sufficient to treat said infection.
-
45. A method of treating onychomycosis in a human, said method comprising administering to the human a therapeutically effective amount of 1,3-dihydro-5-chloro-1-hydroxy-2,1-benzoxaborole, or a pharmaceutically acceptable salt thereof, sufficient to treat said onychomycosis.
-
46. A method of inhibiting the growth of a fungus in a human, said method comprising administering to the human a therapeutically effective amount of 1,3-dihydro-5-chloro-1-hydroxy-2,1-benzoxaborole, or a pharmaceutically acceptable salt thereof.
Specification